Biogen Alzheimer's drug

Trending/Biogen Alzheimer's drug

Alzheimer disease, neuron network with amyloid plaques

FDA approves aducanumab to treat Alzheimer’s disease

The Food and Drug Administration (FDA) approved aducanumab to treat Alzheimer's disease on Monday, June 7. About 6 million people in the U.S. and 30…

No information found.

Sign up